Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × Interleukin-15 × Clear all

NCT04150562 2022-05-17

Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma

Phase 2 Terminated

2 enrolled 13 charts

Carcinoma, Renal Cell